Maciej Kurpisz | Medicine and Dentistry | Best Researcher Award

Posted on by Best Paper Award

Prof Dr. Maciej Kurpisz | Medicine and Dentistry | Best Researcher Award

Maciej Kurpisz at Institute of Human Genetics, Pol Acad Sci, Poland
Summary:

Dr. Maciej K. Kurpisz is a distinguished professor and head of the Department of Reproductive Biology and Stem Cells at the Institute of Human Genetics, Polish Academy of Sciences. With a career spanning over four decades, Dr. Kurpisz has made significant contributions to the fields of reproductive biology, immunology, and stem cell research. He has received numerous honors, including the Prime Minister Award for achievements in reproductive biology, the International Award from the Royan Institute, and the Officer Cross of the Order of Polonia Restituta. He continues to lead groundbreaking research and clinical trials in reproductive health and regenerative medicine.

Professional Profile:

👩‍🎓Education:

  • MD in Medicine: Medical University of Poznan, Poland (1974-1980)
  • MD-Doctorate in Medicine and Immunology: Medical University of Poznan, Poland (1982)
  • Postdoctoral Research in Immunology: London Hospital Medical College, UK (1982-1985)
  • Visiting Scientist in Reproductive Medicine: Oregon Regional Primate Center, Oregon, USA (1985-1986)
  • Visiting Scientist in Reproductive Medicine: Jones Institute for Reproductive Medicine, Virginia, USA (1988-1989)
  • PhD in Reproductive Medicine: Institute of Immunology and Experimental Therapy, Wrocław, Poland (1989)
  • Professor in Genetics: Institute of Human Genetics, Polish Academy of Sciences (1996)

🏢 Professional Experience:

Dr. Kurpisz began his career as a PhD research student and research assistant at the Medical School in Poznan, followed by various academic roles, including Junior and Senior Lecturer, Assistant Professor, and eventually Professor at the Institute of Human Genetics, Polish Academy of Sciences. His international collaborations have included postdoctoral research and visiting scientist positions in the UK and USA. He also held visiting professorships at institutions such as the Deutsche Rheuma Forschungs Zentrum in Berlin and the University of Strathclyde, Glasgow. In the clinical arena, Dr. Kurpisz has extensive experience in andrology and reproductive medicine, working as an infertility consultant in various clinics and contributing to innovative clinical trials involving muscle-derived stem cells for heart disease and reproductive health.

Research Interests:

Dr. Kurpisz’s research focuses on reproductive biology, immunology, and genetics, with a specific interest in male infertility, reproductive immunology, and stem cell applications in regenerative medicine. He has contributed significantly to the molecular understanding of male infertility, reproductive genetics, and the development of novel therapies for post-infarction cardiomyopathy using stem cells. His work also spans clinical trials involving myoblast transplantation for heart disease and genetic modifications in stem cell therapy.

Author Metrics:

  • Publications in refereed journals (SCOPUS): 305
  • Total Publications: 483
  • Sum of Citations: 5,128
  • h-index (Scopus): 42
  • Books and Monographs: 13
  • Book Chapters: 39
  • Doctoral Supervision: 17 doctoral degrees, 6 habilitation promotions, 41 MSc degrees
  • Grants: 10 international, 60 national

Dr. Kurpisz’s prolific research output and his leadership in reproductive medicine and stem cell therapies have established him as a highly regarded expert in his field.

Top Noted Publication:

Epigenetic markers in the embryonal germ cell development and spermatogenesis

  • Authors: Odroniec, A.; Olszewska, M.; Kurpisz, M.
  • Journal: Basic and Clinical Andrology
  • Year: 2023
  • Volume: 33
  • Issue: 1
  • Article Number: 6
  • Citations: 6

Proteomic approach towards identification of seminal fluid biomarkers from individuals with severe oligozoospermia, cryptozoospermia, and non-obstructive azoospermia: A pilot study

  • Authors: Nowicka-Bauer, K.; Kamieniczna, M.; Olszewska, M.; Kurpisz, M.K.
  • Journal: Translational Andrology and Urology
  • Year: 2023
  • Volume: 12
  • Issue: 10
  • Pages: 1497–1510
  • Citations: 2

Long-term cryopreservation of dental stem cells

  • Authors: Brozek, R.; Dorocka-Bobkowska, B.; Kurpisz, M.
  • Journal: Journal of Physiology and Pharmacology
  • Year: 2023
  • Volume: 74
  • Issue: 3
  • Pages: 263–273
  • Citations: 2

Conclusion:

Prof. Dr. Maciej Kurpisz is an exemplary candidate for the Best Researcher Award, recognized for his extensive contributions to reproductive biology, immunology, and stem cell research. His remarkable career, significant publication record, and innovative clinical trials position him as a leading figure in advancing medical science. His experience and recognition in the field further enhance his candidacy. Addressing opportunities for broader international collaboration and public engagement, alongside exploring new research avenues, could elevate his work even further. Overall, Dr. Kurpisz’s ongoing commitment to research and education makes him a deserving nominee for this prestigious award.

 

 

 

Shuying Gao | Pharmaceutical Science | Best Researcher Award

Posted on by Best Paper Award

Prof. Shuying Gao | Pharmaceutical Science | Best Researcher Award

Professor at Harbin Medical University, China

Summary:

Dr. Shuying Gao is an accomplished toxicologist with a focus on the harmful effects of environmental pollutants on human health. With over 20 years of experience, her work delves into the molecular mechanisms that govern pollutant-induced cellular damage, with an emphasis on neurotoxic and immunotoxic responses. She has been a key figure in advancing toxicological research at Harbin Medical University and has contributed to international collaborations that further explore environmental health issues.

Professional Profile:

👩‍🎓Education:

Doctorate in Toxicology – Harbin Medical University, China (Sep 2005 – Nov 2008)

Master of Science (M.S.) in Medical Immunology – Harbin Medical University, China (Sep 2000 – Jul 2003)

Bachelor of Science (B.S.) in Preventive Medicine – Harbin Medical University, China (Sep 1994 – Jul 1999)

🏢 Professional Experience:

Dr. Shuying Gao has been a Professor at the School of Public Health, Harbin Medical University since September 2020. Before her promotion, she served as an Associate Professor at the same institution from September 2009 to August 2020. Her academic journey began as a Lecturer in the School of Public Health at Harbin Medical University (2006-2009). During her tenure, Dr. Gao gained international experience as a Visiting Scholar at the University of Washington’s Department of Environmental Health and Toxicology (April 2013 – April 2014). She has participated in numerous research and consultancy projects related to environmental toxicology, focusing on the impact of environmental pollutants on human health, particularly in the areas of neurotoxicity and immunotoxicity.

Research Interests:

Dr. Gao’s research focuses on toxicological mechanisms associated with environmental pollutants. Her specific interests include studying the effects of chemicals like dibromoacetic acid and diesel exhaust particulates on T-cell apoptosis, blood-brain barrier injury, oxidative stress, and neuroinflammation. She explores pathways such as the MAPK signaling cascade and the RhoA/ROCK signaling pathway to understand pollutant-induced damage.

Author Metric:

  • Google Scholar h-index: 14
  • Google Scholar Citations: 450+
  • Google Scholar i10-index: 12

This biography encapsulates Dr. Gao’s academic background, professional journey, research interests, and contributions to the field of toxicology.

Top Noted Publication:

Title: Enabling Tandem Oxidation of Benzene to Benzenediol over Integrated Neighboring V-Cu Oxides in Mesoporous Silica

  • Journal: Chinese Journal of Chemical Engineering
  • Volume: 55
  • Pages: 236–245
  • Abstract: This research delves into the tandem oxidation of benzene to benzenediol using a V-Cu oxide catalyst housed within mesoporous silica. The study sheds light on the interaction between the neighboring V and Cu oxides, offering potential advancements in the oxidation processes pivotal for chemical manufacturing.
  • Citations: 4

Title: Engineering In-plane π-Conjugated Structures in Ultrathin g-C3N4 Nanosheets for Enhanced Photocatalytic Reduction Performance

  • Journal: Applied Surface Science
  • Volume: 610
  • Article ID: 155574
  • Abstract: The paper explores modifications in g-C3N4 nanosheets, specifically engineering in-plane π-conjugated structures to elevate photocatalytic reduction capabilities. This research is instrumental for improving performance in solar energy applications and environmental cleanup efforts.
  • Citations: 7

Title: Coupling In-plane π-Electrons with Oxygen-Heteroatom in Ultrathin g-C3N4 Nanosheets for Markedly Improved Photodegradation Activity

  • Journal: ACS Applied Optical Materials
  • Volume: 1
  • Issue: 1
  • Pages: 216–228
  • Abstract: This study enhances photodegradation activity by coupling in-plane π-electrons with oxygen heteroatoms in g-C3N4 nanosheets. The findings point toward an innovative approach to boosting photocatalytic degradation efficiency for organic pollutants.
  • Citations: 5

Title: Mesopore-Encaged V-Mn Oxides: Progressive Insertion Approach Triggering Reconstructed Active Sites to Enhance Catalytic Oxidative Desulfuration

  • Journal: Chinese Journal of Chemical Engineering
  • Volume: 45
  • Pages: 182–193
  • Abstract: The research discusses the catalytic oxidative desulfuration process enhanced by mesopore-encaged V-Mn oxides. This work presents a new methodology for the insertion of active sites, which plays a crucial role in sulfur removal from fuel sources.
  • Citations: 8

Title: Engineering Carbon-defects on Ultrathin g-C3N4 Allows One-pot Output and Dramatically Boosts Photoredox Catalytic Activity

  • Journal: Applied Catalysis B: Environmental
  • Volume: 295
  • Article ID: 120272
  • Abstract: This paper focuses on carbon defect engineering in g-C3N4 nanosheets, significantly boosting photoredox catalytic activity. The one-pot synthesis approach enhances the material’s photocatalytic properties, particularly for environmental and energy applications.
  • Citations: 161

Hang Hu | Cancer Photodynamic Therapy | Best Researcher Award

Posted on by Best Paper Award

Dr. Hang Hu, Cancer Photodynamic Therapy, Best Researcher Award

Doctorate at Changzhou University, China

Summary:

Dr. Hang Hu is a dedicated researcher with expertise in cancer photodynamic therapy (PDT) and drug delivery systems. He completed his Bachelor’s degree in Applied Chemistry from Hubei University and pursued both a Master’s and a Doctor’s degree in Organic Chemistry and Biopharmaceutical Engineering at Huazhong University of Science and Technology. Dr. Hu’s research focuses on developing innovative strategies to enhance the efficacy of PDT by addressing challenges such as tumor hypoxia and insufficient photosensitizer uptake. Throughout his career, he has co-authored numerous SCI papers and holds multiple invention patents in the field. Dr. Hu’s work has been recognized for its originality and significance by prestigious journals in the field of materials science and healthcare.

Professional Profile:

Scopus Profile

👩‍🎓Education & Qualification:

Professional experience:  

Dr. Hang Hu has extensive professional experience in the field of cancer photodynamic therapy and drug delivery systems. During graduate studies, Dr. Hu worked on constructing anticancer drug delivery systems using hydroylethyl starch-based materials and subsequently developed nanomedicines for cancer photodynamic therapy. Following the completion of a Doctoral degree, Dr. Hu served as a teacher at the School of Pharmacy, Changzhou University. Throughout this tenure, Dr. Hu’s research focused on cancer photodynamic therapy, with a particular emphasis on developing novel strategies to enhance its effectiveness. This involved the design and development of smart nanomedicines based on various conjugates and drug combinations to address challenges such as tumor hypoxia and intracellular glutathione levels. Dr. Hu has contributed significantly to the field, co-authoring over 40 SCI papers and applying for over 30 invention patents. Additionally, Dr. Hu’s research has been recognized and published in reputable journals, highlighting the originality and significance of the work in cancer therapy and drug delivery systems.

Research Interest:

Dr. Hang Hu’s research interests primarily revolve around cancer photodynamic therapy (PDT) and drug delivery systems. Specifically, Dr. Hu is interested in developing innovative strategies to enhance the efficacy of PDT by addressing key challenges such as tumor hypoxia, high intracellular glutathione levels, and insufficient photosensitizer uptake. This involves the design and synthesis of smart nanomedicines using various materials and drug combinations to potentiate PDT effects. Additionally, Dr. Hu is interested in exploring the mechanisms underlying PDT and the development of novel photosensitizers with improved selectivity and efficacy against cancer cells. The ultimate goal of Dr. Hu’s research is to contribute to the advancement of cancer therapy by developing effective and targeted treatment strategies that minimize side effects and improve patient outcomes.

Publication Top Noted:

Title: Application of mesoporous calcium silicate nanoparticles as a potential SD carrier to improve the solubility of curcumin

  • Authors: Deng, J., Wang, J., Hu, H., Zhou, H., Xu, D.
  • Journal: Journal of Dispersion Science and Technology
  • Year: 2023
  • Volume: 44
  • Citation Count: 4

Title: Conjugates of lactobionic acid and IR820: New photosensitizers for efficient photodynamic therapy of hepatoma cells

  • Authors: Yuan, X., Tao, Y., Xiao, W., Xu, D., Xu, Q.
  • Journal: Drug Development Research
  • Year: 2022
  • Volume: 83
  • Citation Count: 3

Title: pH-Sensitive nanoparticles co-loaded with dimethylcurcumin and regorafenib for targeted combinational therapy of hepatocellular carcinoma

  • Authors: Hu, H., Xu, D.
  • Journal: European Polymer Journal
  • Year: 2022
  • Citation Count: 1

Title: A comparative study of the in vitro antitumor effect of mannose-doxorubicin conjugates with different linkers

  • Authors: Cui, X., Du, K., Yuan, X., Xu, D., Hu, H.
  • Journal: Drug Development Research
  • Year: 2022
  • Volume: 83
  • Citation Count: 4

Title: Mesoporous polydopamine-based multifunctional nanoparticles for enhanced cancer phototherapy

  • Authors: Hu, H., Liu, X., Hong, J., Li, Z., Xu, D.
  • Journal: Journal of Colloid and Interface Science
  • Year: 2022
  • Volume: 612
  • Citation Count: 29